Treatment of type 2 diabetes with bariatric surgery was discussed by several recent publications, including updated guidelines from a group of medical specialty organizations.
Two recent studies looked at cardiovascular disease (CVD) risk in women with type 2 diabetes, finding that fenofibrate may be associated with lowered risk and sulfonylureas with increased risk.
Knowledge among U.S. patients and clinicians about recommended care for diabetes is good but could still use improvement, one can conclude from studies published this month.
Intensive blood pressure control may increase diabetic patients' risk of stroke or coronary heart disease, a group of researchers recently concluded in two separate publications.
The annual meeting of the European Association for the Study of Diabetes was held in Barcelona, Spain in September. Research presented at the meeting covered risks of sulfonylureas, pioglitazone and macular edema, treatment intensification and
Recent evidence suggests it may improve the prognosis of patients with cancer (see the “Keeping tabs” section in this issue).
The benefits of metformin treatment were highlighted by a few intriguing studies published in the past month.
The risks and consequences of hypoglycemia were described by several studies published recently.
Three comparisons of bariatric surgery and medical management for obese type 2 diabetes patients were recently published in journals of the American Medical Association.
Several recent analyses of national health care data assessed the prevalence of diabetes and its complications in the U.S.